Hydrophobic end-gated silica nanotubes for intracellular glutathione-stimulated drug delivery in drug-resistant cancer cells

Chem Commun (Camb). 2013 Apr 21;49(31):3194-6. doi: 10.1039/c3cc38761e. Epub 2013 Feb 15.

Abstract

Intracellular glutathione-triggered doxorubicin release from silica nanotubes with hydrophobic labile cap was demonstrated for the drug-resistant cancer cell treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / toxicity
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / toxicity
  • Drug Carriers / chemistry*
  • Drug Resistance, Neoplasm
  • Glutathione / chemistry
  • Glutathione / metabolism*
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • MCF-7 Cells
  • Mice
  • Mice, Nude
  • Nanotubes / chemistry*
  • Neoplasms / drug therapy
  • Silicon Dioxide / chemistry*
  • Transplantation, Heterologous

Substances

  • Antibiotics, Antineoplastic
  • Drug Carriers
  • Silicon Dioxide
  • Doxorubicin
  • Glutathione